New research from landmark trial suggests a new low for healthy blood pressure
UFDI affiliate researcher Mark S. Segal, M.D., Ph.D. was the principle investigator of the study conducted.
UFDI affiliate researcher Mark S. Segal, M.D., Ph.D. was the principle investigator of the study conducted.
Two recent publications explored different methods of delivering a vaccine for type 1 diabetes, both of which prevented 40 percent of mice from developing the disease.
UFDI faculty and a University of Miami researcher found that “reduced pancreas weight allows for comparisons across a wide range of donor ages by eliminating confounding variables.”…
UFDI researcher Dr. Benjamin Keselowsky’s paper ‘Biomaterials-Based Immunomodulation of Dendritic Cells’ was featured in Laura Santambrogio, M.D., Ph.D.’s latest book, Biomaterials in Regenerative Medicine and the Immune System. You can find Dr. Santambrogio’s book here.
“In less than a decade, nPOD has provided more than 140 research teams with tissues for T1D-related research and grown from 6 collaborating labs to 168 in 17 countries.”…
Dr. Cusi, the Chief of the Division of Endocrinology, Diabetes & Metabolism in the Department of Medicine was featured in the October edition of ‘Current Opinion in Lipidology.’…
From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases: Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes NIH/NIDDK is seeking researchers to conduct advanced clinical trials to test the outpatient clinical safety and efficacy of artificial…
Dr. Campbell-Thompson’s newly released publication showcases evidence that type 1 diabetes is a combined endocrine-exocrine disease in which the loss of functional beta cell mass is clinically apparent.
After isolating and expanding T cells, Dr. Brusko’s lab partnered with biomaterial engineers to create a nanoparticle vaccine to reinvigorate the T cells. Dr. Brusko is highly optimistic.
The paper is titled “C-Abl Inhibitor Imatinib Enhances Insulin Production by β Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2.”…